Imatinib, a 2-phenylaminopyridine-based BCR-ABL tyrosine kinase inhibitor, is a highly effective drug for treating Chronic Myeloid Leukemia (CML). However, cases of drug resistance are constantly emer
Accurate prediction of physicochemical properties such as the octanol water partition coefficient (LogP) is critical in early-stage drug development. This study presents a novel and interpretable comp
